Chapter 83
Popliteal Artery Interventions
Karthik Gujja,
Bhaskar Purushottam,
Vishal Kapur,
Pedro R. Cox-Alomar,
Prakash Krishnan,
Karthik Gujja
Search for more papers by this authorBhaskar Purushottam
Search for more papers by this authorVishal Kapur
Search for more papers by this authorPedro R. Cox-Alomar
Search for more papers by this authorPrakash Krishnan
Search for more papers by this authorKarthik Gujja,
Bhaskar Purushottam,
Vishal Kapur,
Pedro R. Cox-Alomar,
Prakash Krishnan,
Karthik Gujja
Search for more papers by this authorBhaskar Purushottam
Search for more papers by this authorVishal Kapur
Search for more papers by this authorPedro R. Cox-Alomar
Search for more papers by this authorPrakash Krishnan
Search for more papers by this authorBook Editor(s):George D. Dangas MD, MACC, MSCAI, FAHA, FESC,
Carlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC,
Holger Thiele MD,
Peter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP,
Tayo Addo MD, Bimmer Claessen MD, Christian Hengstenberg MD, Nicholas Kipshidze MD,
George D. Dangas MD, MACC, MSCAI, FAHA, FESC
Professor of Medicine (Cardiology) & Surgery (Vascular) Professor of Cardiology Adjunct Professor of Internal Medicine
Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, USA
National Kapodistrian University of Athens, Greece
Medical University of Vienna, Austria
Search for more papers by this authorCarlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC
Professor of Cardiology Director of the Structural Interventional Cardiology Division Honorary Consultant
University of Florence
University Hospital Careggi, Florence, Italy
Cardiologist Royal Brompton Hospital, London, UK
Search for more papers by this authorHolger Thiele MD
Professor of Cardiology at University of Leipzig
Heart Center Leipzig at University of Leipzig, Leipzig, Germany
Search for more papers by this authorPeter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP
Professor of Cardiology Interventional Cardiologist
University of Melbourne, Melbourne, Victoria, Australia
St Vincent's & Northern Hospitals Victoria, Australia
Search for more papers by this authorFirst published: 06 May 2022
Summary
Peripheral Arterial Disease (PAD) affects close to 12 million Americans. It is one of the systemic manifestations of atherosclerosis in the lower extremities. While most patients are asymptomatic, some present with claudication or critical limb ischemia (CLI). PAD is a leading cause of morbidity and mortality in the United States. In advanced disease such as CLI, the one year cardiac mortality is 25 %. The popliteal artery compartment is not devoid of disease. It presents clinically with either atherosclerotic obstructive disease or aneurysm. Therapeutic options for this segment are challenging because this location is particularly exposed to extrinsic forces, which include compression, torsion, kinking and elongation. Even though there is paucity in randomized controlled trials or consensus statements in the management of disease in this compartment, surgical revascularization remains the “gold standard”. Nonetheless, in recent year's endovascular therapy trials have included popliteal lesions, especially in drug-eluting technologies.
References
- Shamoun F , Sural N , Abela G . Peripheral artery disease: therapeutic advances . Exp Rev Cardiovasc Ther 2008 ; 6 ( 4 ): 539 – 553 .
- Hirsch AT , Haskal ZJ , Hertzer NR , et al . ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation . Circulation 2006 ; 113 : e463 – e654 .
- Hirsch A , Haskal Z. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines . Circulation 2006 ; 113 : e463 – 654 .
- Shortell C , Rowe V . Popliteal artery occlusive disease . Medscape. http://emedicine.medscape.com/article/461910-overview (accessed May 29, 2016).
- Norgren L , Hiatt WR , Dormandy JA , et al . GTASC II Working Group . Inter-society consensus for the management of peripheral arterial disease (TASC II) . J Vasc Surg . 2007 ; 45 ( Suppl S ): 5 – 67 .
- Zeller T , Rastan A , Macharzina R , et al . Drug-coated balloons vs drug-eluting stents for treatment of long femoropopliteal lesions . J Endovasc Ther 2014 ; 21 : 359 – 368 .
- Malas M , Enwerem N , Qazi U , et al . Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease . J Vasc Surg 2014 ; 59 ( 1 ): 129 – 135 .
- Scheinert D , Duda S , Zeller T , et al . The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty . JACC Cardiovasc Interv 2014 ; 7 ( 1 ): 10 – 19 .
- Gunner T , Laird J , Schneider P , et al . Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease 12-month results from the IN.PACT SFA Randomized Trial . Circulation 2015 ; 131 : 495 – 502 .
- Micari A , Cioppa A , Vadalà G , et al . 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry . JACC Cardiovasc Interv 2013 ; 6 : 282 – 289 .
- Schroeder H , Meyer DR , Lux B , et al . Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study . Catheter Cardiovasc Interv 2015 ; 86 ( 2 ): 278 – 286 .
- Scheinert D , Scheinert S , Sax J , et al . Prevalence and clinical impact of stent fractures after femoropopliteal stenting . J Am Coll Cardiol. 2005 ; 45 ( 2 ): 312 – 315 .
- León J , Dieter R , Pacanowski J , et al . Clinical research study: preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery . J Vasc Surg 2013 ; 57 : 1014 – 1022 .
- Schillinger M , Minar E . Past, present and future of femoropopliteal stenting . J Endovasc Ther 2009 ; 16 ( Suppl I ): 147 – 152 .
- Mwipatayi B , Hockings A , Hofmann M , et al . Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis . J Vasc Surg 2008 ; 47 : 461 – 469 .
-
Laird JR
.
Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries
.
J Endovasc Ther
2006
;
13
(
Suppl 2
):
30
–
40
.
10.1177/15266028060130S107 Google Scholar
- Geronemus AR , Peña CS . Endovascular treatment of femoral-popliteal disease . Semin Interv Radiol 2009 ; 26 ( 4 ): 303 – 314 .
- Slovut D , Lipsitz E . Surgical technique and peripheral artery disease . Circulation 2012 ; 126 : 1127 – 1138 .
- Semaan E , Hamburg N , Nasr W , et al . Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty . Vasc Endovasc Surg 2010 ; 44 : 25 – 31 .
- Rastan A , Krankenber H , Baumgartner I , et al . Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial . Circulation 2013 ; 127 : 2535 – 2541 .
- Chan Y , Cheng S , Ting A , Cheung G . Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents . J Vasc Surg 2014 ; 59 ( 2 ): 384 – 391 .
- Scheinert D , Werner M , Scheinert S , et al . Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12- month results of the Leipzig SUPERA popliteal artery stent registry . JACC Cardiovasc Interv 2013 ; 6 ( 1 ): 65 – 71 .
- Dake MD , Ansel GM , Jaff MR , et al . Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelvemonth Zilver PTX randomized study results . Circ Cardiovasc Interv 2011 ; 4 : 495 – 504 .
- Dake MD , Ansel GM , Jaff MR , et al . Sustained safety and effectiveness of paclitaxeleluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies . J Am Coll Cardiol 2013 ; 61 : 2417 – 2427 .
- Jahnke T , Mueller-Huelsbeck S , Charalambous N , et al . Prospective, Randomized single-center trial to compare cryoplasty versus conventional angioplasty in the popliteal artery: midterm results of the COLD Study . J Vasc Interv Radiol 2010 ; 21 : 186 – 194 .
-
Samson R
,
Showalter , D
,
Lepore M
,
Ames S
.
CryoPlasty therapy of the superficial femoral and popliteal arteries: a single center experience
.
Vasc Endovasc Surg
2007
;
40
(
6
):
446
–
450
.
10.1177/1538574406290048 Google Scholar
- Zeller T , Rastan A , Sixt S , et al . Long-term results after directional atherectomy of femoro-popliteal lesions . J Am Coll Cardiol 2006 ; 48 ( 8 ): 1573 – 1578 .
- Semaan E , Hamburg N , Nasr W , et al . Endovascular management of the popliteal artery: comparison of atherectomy and angioplasty . Vasc Endovasc Surg 2010 ; 44 : 25 – 31 .
- Wright L , Matchett J , Cruz C , et al . Popliteal artery disease: diagnosis and treatment . RadioGraphics 2004 ; 24 ( 2 ): 467 – 479 .
- Wissgott C , Lüdtke C , Vieweg H , et al . Endovascular treatment of aneurysms of the popliteal artery by a covered endoprosthesis . Clin Med Insights Cardiol 2014 ; 8 ( Suppl 2 ): 15 – 21 .
- Joshi D , James RL , Jones L . Endovascular versus open repair of asymptomatic popliteal artery aneurysm . Cochrane Database Syst Rev 2014 ; 8 : CD010149.
- Wagenhäuser M , Herma K , Sagban T , et al . Long-term results of open repair of popliteal artery aneurysm . Ann Med Surg (Lond) 2015 ; 4 ( 1 ): 58 – 63 .
- Antonello M , Frigatti P , Battocchio P , et al . Endovascular treatment of asymptomatic popliteal aneurysms: 8-year concurrent comparison with open repair . J Cardiovasc Surg (Torino) 2007 ; 48 : 267 .
- Dorweiler B , Gemechu A , Doemland M , et al . Durability of open popliteal artery aneurysm repair . J Vasc Surg 2014 ; 60 : 951 .
- Ying H , Gloviczki P . Popliteal artery aneurysms: rationale, technique, and results of endovascular treatment . Perspect Vasc Surg Endovasc Ther 2008 ; 20 ( 2 ): 201 – 213 .
- Eslami MH , Rybin D , Doros G , Farber A . Open repair of asymptomatic popliteal artery aneurysm is associated with better outcomes than endovascular repair . J Vasc Surg 2015 ; 61 : 663 .
- Huang Y , Gloviczki P , Oderich GS , et al . Outcomes of endovascular and contemporary open surgical repairs of popliteal artery aneurysm . J Vasc Surg 2014 ; 60 : 631 .
- Pulli R , Dorigo W , Castelli P , et al . A Multicentric experience with open surgical repair and endovascular exclusion of popliteal artery aneurysms . Eur J Vasc Endovasc Surg 2013 ; 45 ( 4 ): 357 – 363 .
- Von Stumm M , Teufelsbauer H , Reichenspurnera H , Debusc E.S . Two decades of endovascular repair of popliteal artery aneurysm: a meta-analysis . Eur J Vasc Endovasc Surg 2015 ; 50 ( 3 ): 351 – 359 .
